Sfingolipider
- (2)
- (9)
- (11)
- (2)
- (1)
- (4)
- (3)
- (1)
- (17)
- (8)
- (2)
- (3)
- (1)
- (2)
- (2)
- (2)
- (3)
- (1)
- (1)
- (3)
- (2)
- (3)
- (3)
- (2)
- (4)
- (3)
- (2)
- (2)
- (2)
- (2)
- (3)
- (11)
- (2)
- (1)
- (9)
- (3)
- (8)
- (2)
Filtrerade sökresultat
Invitrogen™ BODIPY™ FL C5 -Ganglioside G M1
Användbar vid cellulär bildbehandling
Invitrogen™ NBD C6 -ceramid (6-(( N- (7-nitrobens-2-Oxa-1,3-diazol-4-yl)amino)hexanoyl)sfingosin)
Selektiv färgning för Golgi-apparater i levande och fixerade celler
Invitrogen™ BODIPY™ FL C5 -Ceramid komplexbunden till BSA
Kan användas i sfingolipidtransport och metabolismmekanismer
Invitrogen™ BODIPY™ TR Ceramid komplexbunden till BSA
Kan användas i sfingolipidtransport och metabolismmekanismer
Invitrogen™ BODIPY™ FL C5- sfingomyelin ( N- (4,4-difluor-5,7-dimetyl-4-bora-3a,4a-diaza- s -indacen-3-pentanoyl)sfingosylfosfokolin)
Användbar vid cellulär bildbehandling
Invitrogen™ BODIPY™ FL C5- ceramid ( N- (4,4-difluor-5,7-dimetyl-4-bora-3a,4a-diaza -s -indacen-3-pentanoyl)sfingosin)
Användbar vid cellulär avbildning och cellspårning och spårning
Invitrogen™ NBD C6 -ceramid komplexbunden till BSA
Selektiv färgning för Golgi-apparater i levande och fixerade celler
Invitrogen™ BODIPY™ FL C12- sfingomyelin ( N- (4,4-difluor-5,7-dimetyl-4-bora-3a,4a-diaza -s -indacen-3-dodekanoyl) sfingosylfosfokolin)
Grönfluorescerande sfingomyelin
Invitrogen™ BODIPY™ FL C5 -Laktosylceramid komplexbunden till BSA
Den grönfluorescerande BODIPY™ FL C 5 laktosylceramid komplexbunden till BSA kan användas i sfingolipidtransport och metabolismmekanismer.
C26-Dihydro Ceramid, TRC
CAS: 182362-38-5 Molekylformel: C44H89NO3 Molekylvikt (g/mol): 680.18 Synonym: [R-(R*,S*)]-N-[2-Hydroxy-1-(hydroxymethyl)heptadecyl]hexacosanamide,C26-Dihydroceramide,C26-Dihydro Ceramide IUPAC-namn: N-[(2S,3R)-1,3-dihydroxyoktadekan-2-yl]hexacosanamid LEDER: CCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)CCCCCCCCCCCCCCC
| Molekylformel | C44H89NO3 |
|---|---|
| IUPAC-namn | N-[(2S,3R)-1,3-dihydroxyoktadekan-2-yl]hexacosanamid |
| CAS | 182362-38-5 |
| LEDER | CCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)CCCCCCCCCCCCCCC |
| Molekylvikt (g/mol) | 680.18 |
| Synonym | [R-(R*,S*)]-N-[2-Hydroxy-1-(hydroxymethyl)heptadecyl]hexacosanamide,C26-Dihydroceramide,C26-Dihydro Ceramide |
C24 Ceramid, TRC
CAS: 34435-05-7 Molekylformel: C42 H83 N O3 Molekylvikt (g/mol): 650.11 Synonym: N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]tetracosanamide,Tetracosanamide, N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]- (9CI),Tetracosanamide, N-[2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-, (E)-D-erythro- (8CI),Tetracosanamide, N-[2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-, [R-[R*,S*-(E)]]-,C24-Ceramide,C24:0 Ceramide,Ceramide (d18:1,C24:0),Ceramide 24,D-erythro-1,3-Dihydroxy-2-tetracosanoylamido-trans-4-octadecene,Lobophytamide L5,N-Lignoceroylsphingosine,N-Tetracosanoyl C18-sphingosine,N-[(1S,2R,3E)-2-Hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]tetracosanamide IUPAC-namn: N-[(E,2S,3R)-1,3-dihydroxyoctadec-4-en-2-yl]tetrakosanamid LEDER: CCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)\C=C\CCCCCCCCCCCCC
| Molekylformel | C42 H83 N O3 |
|---|---|
| IUPAC-namn | N-[(E,2S,3R)-1,3-dihydroxyoctadec-4-en-2-yl]tetrakosanamid |
| CAS | 34435-05-7 |
| LEDER | CCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)\C=C\CCCCCCCCCCCCC |
| Molekylvikt (g/mol) | 650.11 |
| Synonym | N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]tetracosanamide,Tetracosanamide, N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]- (9CI),Tetracosanamide, N-[2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-, (E)-D-erythro- (8CI),Tetracosanamide, N-[2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-, [R-[R*,S*-(E)]]-,C24-Ceramide,C24:0 Ceramide,Ceramide (d18:1,C24:0),Ceramide 24,D-erythro-1,3-Dihydroxy-2-tetracosanoylamido-trans-4-octadecene,Lobophytamide L5,N-Lignoceroylsphingosine,N-Tetracosanoyl C18-sphingosine,N-[(1S,2R,3E)-2-Hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]tetracosanamide |
D-erytro-dihydro-D-sfingosin-1-fosfat, TRC
CAS: 19794-97-9 Molekylformel: C18 H40 N O5 P Molekylvikt (g/mol): 381.49 IUPAC-namn: [(2S,3R)-2-amino-3-hydroxyoktadecyl] divätefosfat LEDER: CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)COP(=O)(O)O
| Molekylformel | C18 H40 N O5 P |
|---|---|
| IUPAC-namn | [(2S,3R)-2-amino-3-hydroxyoktadecyl] divätefosfat |
| CAS | 19794-97-9 |
| LEDER | CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)COP(=O)(O)O |
| Molekylvikt (g/mol) | 381.49 |
C24:1 Ceramid, TRC
CAS: 54164-50-0 Molekylformel: C42 H81 N O3 Molekylvikt (g/mol): 648.1 Synonym: (15Z)-N-[(1S,2R,3E)-2-Hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-15-tetracosenamide,15-Tetracosenamide, N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-, (15Z)- (9CI),15-Tetracosenamide, N-[2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-, [R-[R*,S*-(E,Z)]]-,(15Z)-N-[(1S,2R,3E)-2-Hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-15-tetracosenamide,C24:1-Ceramide,D-erythro-1,3-Dihydroxy-2-(cis-15-tetracosenoylamido)-trans-4-octadecene,N-Nervonoyl-D-sphingosine,N-cis-15-Tetracosenoyl-C18-sphingosine IUPAC-namn: (Z)-N-[(E,2S,3R)-1,3-dihydroxyoktadec-4-en-2-yl]tetrakos-15-enamid LEDER: CCCCCCCCCCCCC\C=C\[C@@H](O)[C@H](CO)NC(=O)CCCCCCCCCCCCC\C=C/CCCCCCCC
| Molekylformel | C42 H81 N O3 |
|---|---|
| IUPAC-namn | (Z)-N-[(E,2S,3R)-1,3-dihydroxyoktadec-4-en-2-yl]tetrakos-15-enamid |
| CAS | 54164-50-0 |
| LEDER | CCCCCCCCCCCCC\C=C\[C@@H](O)[C@H](CO)NC(=O)CCCCCCCCCCCCC\C=C/CCCCCCCC |
| Molekylvikt (g/mol) | 648.1 |
| Synonym | (15Z)-N-[(1S,2R,3E)-2-Hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-15-tetracosenamide,15-Tetracosenamide, N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-, (15Z)- (9CI),15-Tetracosenamide, N-[2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-, [R-[R*,S*-(E,Z)]]-,(15Z)-N-[(1S,2R,3E)-2-Hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-15-tetracosenamide,C24:1-Ceramide,D-erythro-1,3-Dihydroxy-2-(cis-15-tetracosenoylamido)-trans-4-octadecene,N-Nervonoyl-D-sphingosine,N-cis-15-Tetracosenoyl-C18-sphingosine |